This study investigates a brain disorder called tuberous sclerosis complex (TSC) and its connection to a type of abnormal protein buildup known as tau (also referred to as tauopathy), which is commonly associated with neurodegenerative diseases like Alzheimer’s disease. Notably, tauopathy in TSC is free of amyloid plaques, distinguishing it from Alzheimer’s disease. This work opens new opportunities for understanding neurological symptoms of TSC and could encourage the development of new therapies to remove tau in TSC and other neurodegenerative conditions.
Main Purpose of the Study
The primary goal of this research was to determine if the neurological symptoms experienced by adults with TSC, particularly memory and executive function issues, are linked to the accumulation of a specific type of protein called tau. Previous studies had shown elevated levels of this protein in the spinal fluid of TSC patients and suggested its presence in brain scans, but a definitive link to actual tau pathology in the brain was missing due to limitations of the imaging tracer used. This study aimed to clarify if the imaging signal truly corresponded to the accumulation of tau and to identify the specific form of tau involved in TSC.
Methodology Used
The researchers used brain tissue samples from adults with TSC, Alzheimer’s disease (AD), other neurodegenerative conditions, and healthy individuals as controls. They performed detailed analyses using two main techniques:
- Immunohistochemistry (IHC): This involved using special antibodies to identify the tau proteins in the brain tissue.
- AV1451 Staining: They also used the AV1451 tracer, which is used in PET scans, to see if it bound to the same tau protein observed with the antibodies.
The study compared the presence and type of tau pathology across all groups, focusing on specific brain regions linked to memory and executive function. They also checked for the presence of amyloid plaques, another hallmark of Alzheimer’s disease.
Key Findings
- Tau Accumulation in TSC: The study found evidence of tau accumulation in the brains of adult TSC patients, particularly the type of tau also seen in Alzheimer’s disease. However, the density of tau tangles in TSC was lower compared to what is typically seen in Alzheimer’s patients.
- Amyloid-Independent: Importantly, no amyloid plaques were detected in the brains of adult TSC patients. This suggests that the tauopathy in TSC is different from Alzheimer’s disease, which is characterized by both tau and amyloid pathology.
- mTOR Pathway Link: The findings suggest that the overactivity of the mTOR pathway, a known characteristic of TSC, might contribute to the aggregation of Alzheimer’s disease-related tau protein.
Conclusions
This research provides compelling evidence that tuberous sclerosis complex could be considered a novel form of tauopathy, meaning it involves the abnormal accumulation of tau proteins. Importantly, this tauopathy appears to be independent of amyloid plaques, distinguishing it from Alzheimer’s disease. These findings open new avenues for understanding the neurological symptoms in TSC and could lead to the development of new tau targeted therapies for both TSC and other neurodegenerative conditions.
Lead author: Andy J. Liu, MD, Department of Neurology, Duke University School of Medicine, 932 Morreene Rd., Rm 258, Durham, NC 27705
Help the TSC Alliance accelerate TSC research by donating to the 50 Forward Fund!